Filters
Project
Targeted inhibition of BCL2 family proteins in experimental therapy of diffuse large B-cell lymphoma (DLBCL) (NV15-27757A)
Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent type of non-Hodgkin lymphomas (NHL) in the Western hemisphere. BCL2 and MCL1 belong to key regulators of intrinsic (mitochondrial) apoptosis. BCL2 was repeatedly associated with poor...
FD - Onkologie a hematologie
- 2015 - 2018 •
- 6 991 tis. Kč •
- 6 991 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2015 - 31. 12. 2018
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 1 out of 1